Category: Emerging Markets
Healthcare giant Abbott completes enrollment in 3 clinical trials evaluating its novel dissolving, drug-eluting scaffold in patients with blocked heart vessels.
Illinois healthcare titan Abbott (NYSE:ABT) closed 3 clinical trials after enrolling about 2,800 patients in studies of the company's dissolving Absorb drug-eluting scaffold.
The prices of medical devices, whether innovative or commodity, are under significant pressure from all corners and in all parts of the globe, and will continue to be for the foreseeable future.
By Tim Kofol, S2N Health
Medtech titan Boston Scientific plans to sell a slew of its products in Israel through a partnership with distributor Amos Gazit Ltd and marketing group Medison.
Massachusetts medical device maker Boston Scientific (NYSE:BSX) has a new partner in Israel, agreeing to supply a slate of its products through local distributor Amos Gazit Ltd
Boston Scientific's novel lead-free implantable cardioverter defibrillator makes an introduction in the Asia Pacific region.
Massachusetts medical device giant Boston Scientific (NYSE:BSX) is taking its S-ICD lead-free cardiac implant on tour, reaching new regions in Asia Pacific.
Medtech titan Medtronic acquires a controlling stake in Turkish distributor Biostar and pens a new deal to sell Kogent Medical's neurosurgery devices.
Minnesota medical device giant Medtronic (NYSE:MDT) penned a couple of new distribution deals, giving it a controlling stake in a Turkish distributor and expanded access to a Missouri surgical instruments supplier.